Acute Immunological Effects of Exercise in Cancer Patients

Last updated: December 3, 2024
Sponsor: Universität Duisburg-Essen
Overall Status: Active - Not Recruiting

Phase

2

Condition

Cancer

Treatment

High intensity interval exercise training

Clinical Study ID

NCT05656651
ACTIVE
  • Ages > 15
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The aim of the study is to evaluate and compare immune response to a single exercise intervention in cancer patients and healthy age-maged individuals.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Adolescents and young adults >14 years of age

  • undergoing acute cancer treatment (chemotherapy)

  • signed informed consent

Exclusion

Exclusion Criteria:

  • Inability to follow and implement test instructions

  • medical contraindication to HIIT on cycle ergometer

  • chemotherapeutic treatment 48 h prior

  • Hb <8g/dl; platelets < 20,000/ul.

Study Design

Total Participants: 60
Treatment Group(s): 1
Primary Treatment: High intensity interval exercise training
Phase: 2
Study Start date:
December 19, 2022
Estimated Completion Date:
July 31, 2025

Connect with a study center

  • University Hospital Essen

    Essen, NRW 45147
    Germany

    Site Not Available

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.